title: Identification and characterization of a novel Mdm2 splice variant acutely induced by the chemotherapeutic agents adriamycin and actinomycin D.
abstract: Mdm2, as the most important negative regulator of p53, plays an important homeostatic role in regulating cell division and the cellular response to DNA damage, oncogenic insult and other forms of cellular stress. We discovered that the DNA damaging agent adriamycin (doxorubicin) induces a novel aberrantly spliced Mdm2 mRNA which incorporates 108 bp of intronic sequence not normally found in the Mdm2 mature mRNA. Accordingly, we term this Mdm2 splice variant Mdm2(+108). Importantly, this insertion introduces in-frame nonsense codons, thus encoding a profoundly truncated mdm2 protein lacking the C-terminal RING finger domain and the E3 ubiquitin ligase activity. A wide range of pharmacological testing revealed that Mdm2(+108) is induced, in mouse and rat cells, in specific response to Adriamycin and actinomycin D, but not other modes of DNA damage. Meanwhile, antibodies against the N-terminal region of mdm2 reveal a marked reduction in detectable mdm2 protein upon Adriamycin treatment, while p53 accumulates to strikingly high levels. We thus conclude that this alternative spicing of Mdm2 may be an important mechanism to facilitate massive accumulation of p53 in response to genotoxic agents.
authors.affiliation: Department of Sciences, John Jay College of Criminal Justice, The City University of New York, New York, New York 10019, USA. nlents@jjay.cuny.edu
authors.forename: Nathan H
authors.initials: NH
authors.lastname: Lents
authors.forename: Leroy W
authors.initials: LW
authors.lastname: Wheeler
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Baldassare
authors.forename: Brian David
authors.initials: BD
authors.lastname: Dynlacht
mesh_terms: D017398:Alternative Splicing / Q000187:drug effects*; D000818:Animals; D001483:Base Sequence; D015153:Blotting, Western; D002478:Cells, Cultured; D004249:DNA Damage; D003609:Dactinomycin / Q000494:pharmacology*; D004317:Doxorubicin / Q000494:pharmacology*; D051379:Mice; D008969:Molecular Sequence Data; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics* / Q000378:metabolism; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D016159:Tumor Suppressor Protein p53; D003609:Dactinomycin; D004317:Doxorubicin; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2